Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Odyssean IT swings to profit; BMO Cap ups dividend

Fri, 28th May 2021 19:41

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

Love Hemp Group PLC - cannabidiol products maker - Raises GBP2.4 million via subscription of 67.1 million shares at 3.5p each. Says proceeds of the raise will be used for general working capital as well as to support the company's marketing efforts.

----------

Odyssean Investment Trust PLC - investment trust - Reports net asset value per share at March 31 of 139.3p, up from 90.8p a year prior. Pretax profit in the year to March 31 comes in at GBP42.7 million, swinging from GBP4.9 million loss. Does not recommend dividend, and does not expect to do so in the near future. Says it will pay a dividend only if the need arises in order to retain investment trust status.

----------

BMO Capital & Income Investment Trust PLC - investment trust with portfolio consisting mainly of FTSE All-Share companies - Reports NAV per share at March 31, the end of the half-year, of 306.62p, rising from 233.78 a year prior. Declares interim dividend of 5.25p per share, up marginally from a year before. "The company has continued to deliver unbroken growth in annual dividends, retaining its AIC Dividend Hero status. Many investors have suffered reductions in income as dividends have been cut elsewhere and interest rates are so low, but we have always put great emphasis on increasing our dividend each year," says company.

----------

Predator Oil & Gas Holdings PLC - Jersey-based oil & gas company with operations in Trinidad, Morocco and Ireland - Reports widened pretax loss for 2020 of GBP1.7 million from GBP1.3 million a year prior. Administrative expenses rise to GBP1.5 million from GBP1.2 million. Loss per share narrows to 0.8p from 1.2p. "We have eliminated debt, strengthened our balance sheet and further developed our in-country relationships to execute our business strategies and create materiality by aligning with key stakeholders in the energy sectors. With this solid platform we are well-positioned to move forward in 2021 to increase operational activity beginning with the MOU-1 well in northern Morocco, which potentially could lead to the establishment of a new potential gas basin straddling the Maghreb gas pipeline to Europe," says company.

----------

AVI Japan Opportunity Trust PLC - Japan-focused investor - Says tender offer by Secom for its subsidiary company Secom Joshinetsu will boos AJOT's NAV by 3.3%, as Secom Joshinetsu accounts for 5.0% of AJOT's NAV. Tender offer is going for JPY6,350, a 66% premium to the undisturbed closing price of JPY3,820.00 on Friday in Japan.

----------

Mining Minerals & Metals PLC - acquisition vehicle looking for assets in natural resources sector - Reports pretax loss for year to end January of GBP207,612, widening from GBP39,338 a year prior. Administrative expenses up to GBP207,637 from GBP39,338. Does not generate revenue. "The current climate for natural resource companies seeking to raise capital is significantly improving with commodity prices in general performing very well in the second half of 2020 and into 2021. Accordingly, I believe that the company represents an extremely attractive proposition to prospective acquisition counterparties considering listing on the London Stock Exchange and I remain confident that we will be able to execute an acquisition that creates value for our shareholders," says Chair Roy Pitchford.

----------

Rotala PLC - bus operations at Heathrow airport, in West Midlands and North West - Says it continues to operate stably under the umbrella provided by the Coronavirus Bus Services Support Grant regime. "This regime dictates a no profit/no loss outcome at the pre-tax profit line, but does ensure that the company remains cash positive. As the government has eased the restrictions istituted to combat the coronavirus pandemic, passenger volumes have steadily improved. Currently these stand at about 65% of pre-pandemic levels," says company.

----------

Intuitive Investments Group PLC - closed-end investment company focused on life sciences sector - Announces investment of GBP250,000 to acquire 625,000 ordinary shares of Trellus Health PLC at 40 pence per share. Says investment is part of Trellus Health's flotation and associated fundraising. Trellus is a New York-based digital health firm and debuted on AIM on Friday.

----------

Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company focused on hormonal diseases - Receives European Commission approval for drug Efmodym used to treat a rare condition called congenital adrenal hyperplasia. "To facilitate timely commercial availability, Diurnal has already commenced market access activities in its target European territories, with the first commercial launch anticipated in the [third quarter of this year]," says company.

----------

Curzon Energy PLC - investor in US based natural gas projects - Notes exclusivity extension with Poseidon Enhanced Technologies through to July 1. Says they continue to work towards the execution and delivery of a definitive purchase agreement, contemplating a reverse takeover of Curzon by PET.

----------

Gamma Communications PLC - London-based cloud communication services provider - Says it has paid former owners of Exactive Holdings Ltd, which was acquired by Gamma, a further GBP1.5 million. Says it has acquired an additional 8% of the shares of HFO Holding GmbH, now owning a 88% stake, with options to acquire the remaining 12%. HFO is a provider of SIP Trunks and unified communications in Germany. Exactive is a unified communications specialist and is one of a small number of Microsoft Teams voice partners operating in the UK. "Both payments are at the upper end of the possible range which reflects the fact that the underlying performance of both businesses has been strong since acquisition," says company.

----------

Globalworth Real Estate Investments Ltd - real estate investor - Says offer by CPI Property Group SA and Aroundtown SA at EUR7.00 per Globaworth share "significantly undervalues Globalworth, its assets and its prospects". Globalworth shares closed down at EUR7.16 each in London on Friday.

----------

Armadale Capital PLC - investment company focused on natural resource projects in Africa - Reports narrowed loss in 2020 of GBP195,925 from GBP272,548. Administrative expenses fall to GBP377,912 from GBP468,948. Raises GBP850,000 via a private subscription with "existing high-net worth shareholders in the company". Says funds will strengthen the company's balance sheet as it seeks to progress development finance workstreams ahead of construction at Mahenge graphite project in Tanzania.

----------

EQTEC PLC - Cork, Ireland-based gasification technology company for sustainable waste-to-energy project - Raises GBP16 million via oversubscribed placing of 66.6 million shares at 1.5p each.

----------

Oxford BioMedica PLC - Oxford, England-based gene and cell therapy - Sees 18% of votes cast at AGM against amending rules of 2015 long-term incentive plan, as well as the amending rules of the 2015 executive share option scheme.

----------

Ashoka India Equity Investment Trust PLC - India-focused investment trust - Proposes further issuance of shares via an initial placing, offer for subscription and intermediaries offer. "The board is very satisfied with the performance of the bompany since its IPO in 2018, for which huge credit is due to the White Oak team. India is currently faced with the challenge of the second wave of the Covid-19 virus, and the thoughts of my fellow directors and I are with the people of India. India remains an attractive, long-term investment, and the board continues to believe that there is a compelling investment opportunity, which plays strongly to our manager's bottom-up approach to stock selection," sat Chair Andrew Watkins.

----------

By Greg Roxburgh; gregroxburgh@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
10 Jan 2019 11:33

Diurnal Shares Surge As Secures Second Patent For Chronocort In US

LONDON (Alliance News) - Diurnal Group PLC on Thursday said the US Patent & Trademark Office has granted the company a second US patent for Chronocort.Diurnal shares almost tripled on a

Read more
10 Jan 2019 11:26

Diurnal awarded US patent for Chronocort product

(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced on Thursday that the US Patent and Trademark Office (USPTO) has granted a second US patent for its 'Chronocort' modified release hydrocortisone product.

Read more
17 Oct 2018 12:10

Diurnal halts US development of Chronocort after European trials come up short

(Sharecast News) - Speciality pharmaceutical company Diurnal has put all development activities for its modified release hydrocortisone product on hold after it failed to meet its primary endpoint in a recent phase-three European trial.

Read more
17 Oct 2018 10:41

Diurnal Puts All Chronocort US Development Activities On Hold

LONDON (Alliance News) - Diurnal Group PLC said Wednesday it decided to put all US development activities for its Chronocort product on hold, after it failed to meet its primary objective in its a

Read more
8 Oct 2018 17:07

LONDON MARKET CLOSE: Stocks End Lower On Chinese And Italian Woes

LONDON (Alliance News) - Stocks closed lower Monday on the actions of the Chinese and Italian governments, as the pound continued its fall on news from 10 Downing Street there remains "big in of

Read more
8 Oct 2018 15:15

Diurnal Group Child Adrenal Insufficiency Drug Approved In Scotland

LONDON (Alliance News) - Diurnal Group PLC said Monday the Scottish Medicines Consortium approved the routine use of Alkindi, a first-line treatment of young children with adrenal insufficiency to

Read more
8 Oct 2018 12:00

LONDON MARKET MIDDAY: China Prompts Sell-Off In Europe; Insurers Fall

LONDON (Alliance News) - Share prices in London had slipped firmly into the red by midday on Monday following a slump in Chinese equities overnight."Europe is following the Asian lead, with a 3%

Read more
8 Oct 2018 10:33

WINNERS & LOSERS SUMMARY: French Connection In Vogue On Possible Sale

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - up 1.0%. The asset manager confirmed it is in to

Read more
8 Oct 2018 09:29

Diurnal's endocrine drug does not meet trial objective

(Sharecast News) - Clinical trials of Diurnal Group's Chronocort drug failed to meet the primary objective of proving superior to conventional therapy in endocrine control over a 24-hour period.

Read more
8 Oct 2018 08:54

Shares In IP Group, Diurnal Suffer After Chronocort Trial Disappoints

LONDON (Alliance News) - Diurnal Group PLC said Monday its phase-three European trial of Chronocort did not meet its primary objective, causing shares in the pharmaceutical company to property IP

Read more
8 Oct 2018 07:48

LONDON MARKET PRE-OPEN: Lower Call; Schroders Confirms Lloyds Talks

LONDON (Alliance News) - Stocks in London on Monday are set to continue last week's slide, fuelled by concerns that strong US economic data will lead to a quickened pace of interest rate hikes.In

Read more
5 Oct 2018 09:20

Diurnal kicks off adrenal condition trial with first patients

(Sharecast News) - Specialist pharmaceutical company Diurnal said it had enrolled the first two patients in its US-based Chronocort phase III trial for adults with congenital adrenal hyperplasia (CAH).

Read more
5 Oct 2018 08:16

Diurnal Enrols First Patients In Phase Three US Chronocort Trial

LONDON (Alliance News) - Pharmaceutical company Diurnal Group PLC on Friday said the first two patients have been enrolled into its phase three US trial of Chronocort.Chronocort is a form a

Read more
20 Sep 2018 09:56

Diurnal Generates First Revenue But Loss Deepens As Costs Rise

LONDON (Alliance News) - Pharmaceutical firm Diurnal Group PLC said Thursday its annual loss deepened amid higher costs despite generating its first revenue from drug sales.For the year the

Read more
15 Aug 2018 12:39

German Body Says Diurnal Alkindi's Benefit Over Generic Not Proven

LONDON (Alliance News) - Diurnal Group PLC said Wednesday a German body published a study which says that the benefit of the company's product Alkindi over generic hydrocortisone has not been

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.